Global Myotonic Dystrophy Type 1 (DM1) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 101

Published Date: 07 Jun 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The Myotonic Dystrophy Type 1 (DM1) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Myotonic Dystrophy Type 1 (DM1) market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Hospitals accounting for % of the Myotonic Dystrophy Type 1 (DM1) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Exondys segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Myotonic Dystrophy Type 1 (DM1) include Dyne, Audentes, Pfizer, Vertex, and PepGen, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Myotonic Dystrophy Type 1 (DM1) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Exondys
    Emflaza
    Translarna

Market segment by Application can be divided into
    Hospitals
    Clinics
    Home Care

The key market players for global Myotonic Dystrophy Type 1 (DM1) market are listed below:
    Dyne
    Audentes
    Pfizer
    Vertex
    PepGen
    NeuBase Therapeutics
    Lupin
    AMO Pharma
    Expansion Therapeutics
    Harmony Biosciences

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Myotonic Dystrophy Type 1 (DM1) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Myotonic Dystrophy Type 1 (DM1), with price, sales, revenue and global market share of Myotonic Dystrophy Type 1 (DM1) from 2019 to 2022.
Chapter 3, the Myotonic Dystrophy Type 1 (DM1) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Myotonic Dystrophy Type 1 (DM1) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Myotonic Dystrophy Type 1 (DM1) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Myotonic Dystrophy Type 1 (DM1).
Chapter 13, 14, and 15, to describe Myotonic Dystrophy Type 1 (DM1) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Myotonic Dystrophy Type 1 (DM1) Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Exondys
        1.2.3 Emflaza
        1.2.4 Translarna
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home Care
    1.4 Global Myotonic Dystrophy Type 1 (DM1) Market Size & Forecast
        1.4.1 Global Myotonic Dystrophy Type 1 (DM1) Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Myotonic Dystrophy Type 1 (DM1) Sales in Volume (2017-2028)
        1.4.3 Global Myotonic Dystrophy Type 1 (DM1) Price (2017-2028)
    1.5 Global Myotonic Dystrophy Type 1 (DM1) Production Capacity Analysis
        1.5.1 Global Myotonic Dystrophy Type 1 (DM1) Total Production Capacity (2017-2028)
        1.5.2 Global Myotonic Dystrophy Type 1 (DM1) Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Myotonic Dystrophy Type 1 (DM1) Market Drivers
        1.6.2 Myotonic Dystrophy Type 1 (DM1) Market Restraints
        1.6.3 Myotonic Dystrophy Type 1 (DM1) Trends Analysis

2 Manufacturers Profiles
    2.1 Dyne
        2.1.1 Dyne Details
        2.1.2 Dyne Major Business
        2.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.1.4 Dyne Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Audentes
        2.2.1 Audentes Details
        2.2.2 Audentes Major Business
        2.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.2.4 Audentes Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.3.4 Pfizer Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Vertex
        2.4.1 Vertex Details
        2.4.2 Vertex Major Business
        2.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.4.4 Vertex Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 PepGen
        2.5.1 PepGen Details
        2.5.2 PepGen Major Business
        2.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.5.4 PepGen Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 NeuBase Therapeutics
        2.6.1 NeuBase Therapeutics Details
        2.6.2 NeuBase Therapeutics Major Business
        2.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.6.4 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Lupin
        2.7.1 Lupin Details
        2.7.2 Lupin Major Business
        2.7.3 Lupin Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.7.4 Lupin Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 AMO Pharma
        2.8.1 AMO Pharma Details
        2.8.2 AMO Pharma Major Business
        2.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.8.4 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Expansion Therapeutics
        2.9.1 Expansion Therapeutics Details
        2.9.2 Expansion Therapeutics Major Business
        2.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.9.4 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Harmony Biosciences
        2.10.1 Harmony Biosciences Details
        2.10.2 Harmony Biosciences Major Business
        2.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product and Services
        2.10.4 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Myotonic Dystrophy Type 1 (DM1) Breakdown Data by Manufacturer
    3.1 Global Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Myotonic Dystrophy Type 1 (DM1)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Myotonic Dystrophy Type 1 (DM1) Manufacturer Market Share in 2021
        3.4.2 Top 6 Myotonic Dystrophy Type 1 (DM1) Manufacturer Market Share in 2021
    3.5 Global Myotonic Dystrophy Type 1 (DM1) Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Myotonic Dystrophy Type 1 (DM1) Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size by Region
        4.1.1 Global Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Region (2017-2028)
        4.1.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2028)
    4.2 North America Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028)
    4.3 Europe Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028)
    4.4 Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028)
    4.5 South America Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028)
    4.6 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Type (2017-2028)
    5.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type (2017-2028)
    5.3 Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Application (2017-2028)
    6.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application (2017-2028)
    6.3 Global Myotonic Dystrophy Type 1 (DM1) Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2028)
    7.2 North America Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2028)
    7.3 North America Myotonic Dystrophy Type 1 (DM1) Market Size by Country
        7.3.1 North America Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Country (2017-2028)
        7.3.2 North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2028)
    8.2 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2028)
    8.3 Europe Myotonic Dystrophy Type 1 (DM1) Market Size by Country
        8.3.1 Europe Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Country (2017-2028)
        8.3.2 Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2028)
    9.2 Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2028)
    9.3 Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Market Size by Region
        9.3.1 Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2028)
    10.2 South America Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2028)
    10.3 South America Myotonic Dystrophy Type 1 (DM1) Market Size by Country
        10.3.1 South America Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Country (2017-2028)
        10.3.2 South America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2028)
    11.2 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2028)
    11.3 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Market Size by Country
        11.3.1 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Myotonic Dystrophy Type 1 (DM1) and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Myotonic Dystrophy Type 1 (DM1)
    12.3 Myotonic Dystrophy Type 1 (DM1) Production Process
    12.4 Myotonic Dystrophy Type 1 (DM1) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Myotonic Dystrophy Type 1 (DM1) Typical Distributors
    13.3 Myotonic Dystrophy Type 1 (DM1) Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Dyne Basic Information, Manufacturing Base and Competitors
    Table 4. Dyne Major Business
    Table 5. Dyne Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 6. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Audentes Basic Information, Manufacturing Base and Competitors
    Table 8. Audentes Major Business
    Table 9. Audentes Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 10. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 12. Pfizer Major Business
    Table 13. Pfizer Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 14. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Vertex Basic Information, Manufacturing Base and Competitors
    Table 16. Vertex Major Business
    Table 17. Vertex Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 18. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. PepGen Basic Information, Manufacturing Base and Competitors
    Table 20. PepGen Major Business
    Table 21. PepGen Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 22. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. NeuBase Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 24. NeuBase Therapeutics Major Business
    Table 25. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 26. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Lupin Basic Information, Manufacturing Base and Competitors
    Table 28. Lupin Major Business
    Table 29. Lupin Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 30. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. AMO Pharma Basic Information, Manufacturing Base and Competitors
    Table 32. AMO Pharma Major Business
    Table 33. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 34. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Expansion Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 36. Expansion Therapeutics Major Business
    Table 37. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 38. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Harmony Biosciences Basic Information, Manufacturing Base and Competitors
    Table 40. Harmony Biosciences Major Business
    Table 41. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product and Services
    Table 42. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Global Myotonic Dystrophy Type 1 (DM1) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
    Table 44. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 45. Market Position of Manufacturers in Myotonic Dystrophy Type 1 (DM1), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 46. Global Myotonic Dystrophy Type 1 (DM1) Production Capacity by Company, (Units): 2020 VS 2021
    Table 47. Head Office and Myotonic Dystrophy Type 1 (DM1) Production Site of Key Manufacturer
    Table 48. Myotonic Dystrophy Type 1 (DM1) New Entrant and Capacity Expansion Plans
    Table 49. Myotonic Dystrophy Type 1 (DM1) Mergers & Acquisitions in the Past Five Years
    Table 50. Global Myotonic Dystrophy Type 1 (DM1) Sales by Region (2017-2022) & (Units)
    Table 51. Global Myotonic Dystrophy Type 1 (DM1) Sales by Region (2023-2028) & (Units)
    Table 52. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2022) & (USD Million)
    Table 53. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2023-2028) & (USD Million)
    Table 54. Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)
    Table 55. Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (2023-2028) & (Units)
    Table 56. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type (2017-2022) & (USD Million)
    Table 57. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type (2023-2028) & (USD Million)
    Table 58. Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2017-2022) & (US$/Unit)
    Table 59. Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2023-2028) & (US$/Unit)
    Table 60. Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)
    Table 61. Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2023-2028) & (Units)
    Table 62. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application (2017-2022) & (USD Million)
    Table 63. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application (2023-2028) & (USD Million)
    Table 64. Global Myotonic Dystrophy Type 1 (DM1) Price by Application (2017-2022) & (US$/Unit)
    Table 65. Global Myotonic Dystrophy Type 1 (DM1) Price by Application (2023-2028) & (US$/Unit)
    Table 66. North America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)
    Table 67. North America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2023-2028) & (Units)
    Table 68. North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & (USD Million)
    Table 69. North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2023-2028) & (USD Million)
    Table 70. North America Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)
    Table 71. North America Myotonic Dystrophy Type 1 (DM1) Sales by Type (2023-2028) & (Units)
    Table 72. North America Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)
    Table 73. North America Myotonic Dystrophy Type 1 (DM1) Sales by Application (2023-2028) & (Units)
    Table 74. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)
    Table 75. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2023-2028) & (Units)
    Table 76. Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & (USD Million)
    Table 77. Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2023-2028) & (USD Million)
    Table 78. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)
    Table 79. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Type (2023-2028) & (Units)
    Table 80. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)
    Table 81. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Application (2023-2028) & (Units)
    Table 82. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region (2017-2022) & (Units)
    Table 83. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region (2023-2028) & (Units)
    Table 84. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2022) & (USD Million)
    Table 85. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2023-2028) & (USD Million)
    Table 86. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)
    Table 87. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Type (2023-2028) & (Units)
    Table 88. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)
    Table 89. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Application (2023-2028) & (Units)
    Table 90. South America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)
    Table 91. South America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2023-2028) & (Units)
    Table 92. South America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & (USD Million)
    Table 93. South America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2023-2028) & (USD Million)
    Table 94. South America Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)
    Table 95. South America Myotonic Dystrophy Type 1 (DM1) Sales by Type (2023-2028) & (Units)
    Table 96. South America Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)
    Table 97. South America Myotonic Dystrophy Type 1 (DM1) Sales by Application (2023-2028) & (Units)
    Table 98. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Region (2017-2022) & (Units)
    Table 99. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Region (2023-2028) & (Units)
    Table 100. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2022) & (USD Million)
    Table 101. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2023-2028) & (USD Million)
    Table 102. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)
    Table 103. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Type (2023-2028) & (Units)
    Table 104. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Application (2017-2022) & (Units)
    Table 105. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Application (2023-2028) & (Units)
    Table 106. Myotonic Dystrophy Type 1 (DM1) Raw Material
    Table 107. Key Manufacturers of Myotonic Dystrophy Type 1 (DM1) Raw Materials
    Table 108. Direct Channel Pros & Cons
    Table 109. Indirect Channel Pros & Cons
    Table 110. Myotonic Dystrophy Type 1 (DM1) Typical Distributors
    Table 111. Myotonic Dystrophy Type 1 (DM1) Typical Customers
List of Figures
    Figure 1. Myotonic Dystrophy Type 1 (DM1) Picture
    Figure 2. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Type in 2021
    Figure 3. Exondys
    Figure 4. Emflaza
    Figure 5. Translarna
    Figure 6. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Application in 2021
    Figure 7. Hospitals
    Figure 8. Clinics
    Figure 9. Home Care
    Figure 10. Global Myotonic Dystrophy Type 1 (DM1) Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
    Figure 11. Global Myotonic Dystrophy Type 1 (DM1) Revenue and Forecast (2017-2028) & (USD Million)
    Figure 12. Global Myotonic Dystrophy Type 1 (DM1) Sales (2017-2028) & (Units)
    Figure 13. Global Myotonic Dystrophy Type 1 (DM1) Price (2017-2028) & (US$/Unit)
    Figure 14. Global Myotonic Dystrophy Type 1 (DM1) Production Capacity (2017-2028) & (Units)
    Figure 15. Global Myotonic Dystrophy Type 1 (DM1) Production Capacity by Geographic Region: 2022 VS 2028
    Figure 16. Myotonic Dystrophy Type 1 (DM1) Market Drivers
    Figure 17. Myotonic Dystrophy Type 1 (DM1) Market Restraints
    Figure 18. Myotonic Dystrophy Type 1 (DM1) Market Trends
    Figure 19. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Manufacturer in 2021
    Figure 20. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Manufacturer in 2021
    Figure 21. Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 22. Top 3 Myotonic Dystrophy Type 1 (DM1) Manufacturer (Revenue) Market Share in 2021
    Figure 23. Top 6 Myotonic Dystrophy Type 1 (DM1) Manufacturer (Revenue) Market Share in 2021
    Figure 24. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2028)
    Figure 25. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2017-2028)
    Figure 26. North America Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028) & (USD Million)
    Figure 27. Europe Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028) & (USD Million)
    Figure 28. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028) & (USD Million)
    Figure 29. South America Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028) & (USD Million)
    Figure 30. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue (2017-2028) & (USD Million)
    Figure 31. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2028)
    Figure 32. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Type (2017-2028)
    Figure 33. Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2017-2028) & (US$/Unit)
    Figure 34. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2028)
    Figure 35. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Application (2017-2028)
    Figure 36. Global Myotonic Dystrophy Type 1 (DM1) Price by Application (2017-2028) & (US$/Unit)
    Figure 37. North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2028)
    Figure 38. North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2028)
    Figure 39. North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2028)
    Figure 40. North America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2028)
    Figure 41. United States Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Canada Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Mexico Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2028)
    Figure 45. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2028)
    Figure 46. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2028)
    Figure 47. Europe Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2028)
    Figure 48. Germany Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. France Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. United Kingdom Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Russia Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Italy Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2028)
    Figure 54. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2028)
    Figure 55. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2028)
    Figure 56. Asia-Pacific Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2017-2028)
    Figure 57. China Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Japan Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Korea Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. India Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Southeast Asia Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Australia Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. South America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2028)
    Figure 64. South America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2028)
    Figure 65. South America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2028)
    Figure 66. South America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2028)
    Figure 67. Brazil Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Argentina Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2028)
    Figure 70. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2028)
    Figure 71. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2028)
    Figure 72. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2017-2028)
    Figure 73. Turkey Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Egypt Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. South Africa Myotonic Dystrophy Type 1 (DM1) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Manufacturing Cost Structure Analysis of Myotonic Dystrophy Type 1 (DM1) in 2021
    Figure 78. Manufacturing Process Analysis of Myotonic Dystrophy Type 1 (DM1)
    Figure 79. Myotonic Dystrophy Type 1 (DM1) Industrial Chain
    Figure 80. Sales Channel: Direct Channel vs Indirect Channel
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Dyne
Audentes
Pfizer
Vertex
PepGen
NeuBase Therapeutics
Lupin
AMO Pharma
Expansion Therapeutics
Harmony Biosciences

Product Tags

myotonic dystrophy 1 dm1

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>